Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.3 and no longer displays Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-08T12:24:22.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision history updated: added entry v3.4.2 and removed entry v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-14T14:42:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision v3.4.1 was added to the history, and revision v3.4.0 was removed.
    Difference
    0.1%
    Check dated 2026-02-07T09:14:16.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, color-coded change highlights (green for additions, red for deletions), and a revision label (v3.4.0).
    Difference
    1.0%
    Check dated 2026-01-24T04:50:04.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the Record History, and the previous entry v3.3.3 was removed. This update affects only metadata and does not alter study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T03:20:58.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.2%
    Check dated 2025-12-19T12:42:04.000Z thumbnail image

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.